微小残留病监测是否应成为所有急性早幼粒细胞白血病患者的治疗标准？ - Suppr

Should minimal residual disease monitoring be the standard of care for all patients with acute promyelocytic leukemia?

作者信息

Grimwade David, Tallman Martin S

出版信息

Leuk Res. 2011 Jan;35(1):3-7. doi: 10.1016/j.leukres.2010.06.018. Epub 2010 Jul 31.

DOI:10.1016/j.leukres.2010.06.018

PMID:20674017

Abstract

摘要

相似文献

Should minimal residual disease monitoring be the standard of care for all patients with acute promyelocytic leukemia?

Leuk Res. 2011 Jan;35(1):3-7. doi: 10.1016/j.leukres.2010.06.018. Epub 2010 Jul 31.

Monitoring of minimal residual disease in acute promyelocytic leukemia.

Ann Hematol. 2004;83 Suppl 1:S79-80. doi: 10.1007/s00277-004-0850-2.

Interferon enhanced minimal residual disease detection in acute promyelocytic leukaemia.

Br J Haematol. 1997 Mar;96(4):876-7.

Role of autologous bone marrow transplantation as consolidation therapy in acute promyelocytic leukemia patients in complete remission.

Haematologica. 1998 Nov;83(11):1051-5.

Acute promyelocytic leukemia: a paradigm for differentiation therapy.

Cancer Treat Res. 2010;145:219-35. doi: 10.1007/978-0-387-69259-3_13.

Minimal residual disease in acute promyelocytic leukemia.

Clin Lab Med. 2000 Mar;20(1):105-17, ix.

Acute promyelocytic leukaemia (APL): chemotherapy or bone marrow transplantation?

Bone Marrow Transplant. 1989 Dec;4 Suppl 3:102.

The significance of minimal residual disease kinetics in adults with newly diagnosed PML-RARalpha-positive acute promyelocytic leukemia: results of a prospective trial.

Haematologica. 2006 May;91(5):671-4. Epub 2006 Apr 19.

[Monitoring of minimal residual disease in patients with acute promyelocytic leukemia].

Ter Arkh. 2006;78(7):25-31.

Acute promyelocytic leukemia: from treatment to genetics and back.

Oncogene. 1999 Sep 20;18(38):5261-7. doi: 10.1038/sj.onc.1202996.

引用本文的文献

Autologous is superior to allogeneic hematopoietic cell transplantation for acute promyelocytic leukemia in second complete remission.

Biol Blood Marrow Transplant. 2014 Jul;20(7):1021-5. doi: 10.1016/j.bbmt.2014.03.025. Epub 2014 Mar 30.

Development of real-time quantitative polymerase chain reaction assays to track treatment response in retinoid resistant acute promyelocytic leukemia.

Front Oncol. 2011 Oct 25;1:35. doi: 10.3389/fonc.2011.00035. eCollection 2011.

Quantification of PML/RARa transcript after induction predicts outcome in children with acute promyelocytic leukemia.

Int J Hematol. 2012 May;95(5):500-8. doi: 10.1007/s12185-012-1034-9. Epub 2012 Mar 10.

Curing all patients with acute promyelocytic leukemia: are we there yet?

Hematol Oncol Clin North Am. 2011 Dec;25(6):1215-33, viii. doi: 10.1016/j.hoc.2011.10.002.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Should minimal residual disease monitoring be the standard of care for all patients with acute promyelocytic leukemia?

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Should minimal residual disease monitoring be the standard of care for all patients with acute promyelocytic leukemia?

作者信息

出版信息

相似文献

引用本文的文献